drugset / Trial / NCT01520987

Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects

NCT01520987

Phase 1 Completed 105 enrolled Bial - Portela C S.A.
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the pharmacokinetics of BIA 9-1067 in healthy Japanese subjects

Timeline

Start
2011-05
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Opicapone Small molecule 5 mg
Subject Opicapone Small molecule 25 mg
Subject Opicapone Small molecule 50 mg

Indications